China Pharma (NYSE:CPHI) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Down 3.9 %

China Pharma stock opened at $0.26 on Friday. The company’s 50 day moving average is $0.23 and its two-hundred day moving average is $0.22. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 52-week low of $0.13 and a 52-week high of $0.41.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.